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Long-term exposure to particulate air pollu-
tion, including diesel exhaust, is associated
with an increasing incidence of respiratory
allergy, cardiopulmonary mortality, and risk
of lung cancer (Pope et al. 2002; Sydbom
et al. 2001). Although the health effects of
diesel exhaust particles (DEPs) have been
studied for many years (Lewtas 1982), a com-
prehensive identiﬁcation of the chemical com-
ponents responsible for the biologic effects
and a full understanding of the underlying
mechanisms remain incomplete (Mauderly
2001; Rosenkranz 1996).
The two most-studied health effects of
DEPs are pulmonary toxicity and mutagenic-
ity, and different chemical and physical fea-
tures of DEPs have been associated with the
induction of these two end points. For muta-
genicity, early studies suggested that nitro-
arenes were a primary class of mutagens in
organic extracts of DEPs (Austin et al. 1985;
Claxton 1981; Claxton and Huisingh 1980);
analytical studies conﬁrmed this (Paputa-Peck
et al. 1983; Salmeen et al. 1982) and also
identiﬁed a role for polycyclic aromatic hydro-
carbons (PAHs) (Rosenkranz 1996). For pul-
monary effects, some PAHs have been shown
to enhance pro-inflammatory and allergic
responses induced by DEPs in the airways
(Diaz-Sanchez 1997; Kawasaki et al. 2001;
Tsien et al. 1997). However, the size and
surface reactivity of particles also may play a
role in the induction of pulmonary effects
(Dick et al. 2003; Donaldson et al. 1996).
Many studies of the mutagenicity of
DEPs have been conducted using a standard
reference material (SRM), such as SRM
2975, which was derived from a forklift truck
and developed by the National Institute of
Standards and Technology (NIST) (Claxton
et al. 1992; Hughes et al. 1997); however,
only a few studies have characterized the pul-
monary effects of this sample (Lovik et al.
1997; Madden et al. 2000). In contrast,
many studies on the pulmonary toxicity of
DEPs have used an automobile-derived DEP
sample (A-DEP) (Kobayashi and Ito 1995;
Sagai et al. 1993), but the mutagenicity of
this DEP sample has not been reported.
Although Seagrave et al. (2002) have exam-
ined the same DEPs for pulmonary effects as
well as mutagenicity, no one has done so for
the extensively studied A-DEP sample.
The chemical composition of DEPs is
inﬂuenced by the age and type of engine, fuel
composition, load characteristics, lube oil com-
ponents, presence and efficiency of control
devices, and sampling procedures (Claxton
1983; Mauderly 2001; Rosenkranz 1996;
Schuetzle 1983). Given that these factors vary
for the SRM and A-DEP samples, we reasoned
that the biologic activities of these DEPs were
likely to be different. To assess the potential
impact of these differences on mutagenicity,
we evaluated the two DEP samples using a
bioassay-directed fractionation (Schuetzle and
Lewtas 1986) coupled with the Salmonella
mutagenicity assay.
Various DEP samples have been subjected
to such analyses since the first report
(Huisingh et al. 1979), including an earlier
SRM of DEPs, SRM 1650 (Savard et al.
1992). In this study, we sequentially extracted
an organic extract of each DEP with solvents
of increasing polarity on a silica-gel column
and then evaluated the fractions for muta-
genicity in various strains of Salmonella. The
results were expressed as the distribution of
mass and mutagenicity among the fractions.
Combined with physical and chemical fea-
tures of these DEPs, as well as their pul-
monary toxicities (Singh et al. 2004), we
propose that DEP samples should be charac-
terized chemically, physically, and biologically
at multiple end points to understand the
mechanisms associated with the health effects
of DEPs.
Materials and Methods
Generation and collection of DEPs. A-DEPs
were provided by one of the authors (T.K.),
and the generation and collection conditions of
these DEPs have been described previously
(Kobayashi and Ito 1995; Sagai et al. 1993).
Brieﬂy, DEPs were collected “cold” at a sam-
pling temperature of 50°C onto glass-fiber
filters (GD-100R, 203 mm × 254 mm) in a
constant-volume sampling system ﬁtted at the
end of a dilution tunnel. The particles were
generated using a light-duty (2,740 cc), 4-cylin-
der, 4JB1-type Isuzu diesel engine. The engine
had a torque load of 6 kg/m generated by an
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Many pulmonary toxicity studies of diesel exhaust particles (DEPs) have used an automobile-
generated sample (A-DEPs) whose mutagenicity has not been reported. In contrast, many muta-
genicity studies of DEPs have used a forklift-generated sample (SRM 2975) that has been evaluated
in only a few pulmonary toxicity studies. Therefore, we evaluated the mutagenicity of both DEPs
in Salmonella coupled to a bioassay-directed fractionation. The percentage of extractable organic
material (EOM) was 26.3% for A-DEPs and 2% for SRM 2975. Most of the A-EOM (~55%)
eluted in the hexane fraction, reﬂecting the presence of alkanes and alkenes, typical of uncombusted
fuel. In contrast, most of the SRM 2975 EOM (~58%) eluted in the polar methanol fraction,
indicative of oxygenated and/or nitrated organics derived from combustion. Most of the direct-
acting, base-substitution activity of the A-EOM eluted in the hexane/dichloromethane (DCM) frac-
tion, but this activity eluted in the polar methanol fraction for the SRM 2975 EOM. The direct-
acting frameshift mutagenicity eluted across fractions of A-EOM, whereas > 80% eluted only in the
DCM fraction of SRM 2975 EOM. The A-DEPs were more mutagenic than SRM 2975 per mass
of particle, having 227× more polycyclic aromatic hydrocarbon–type and 8–45× more nitroarene-
type mutagenic activity. These differences were associated with the different conditions under
which the two DEP samples were generated and collected. A comprehensive understanding of the
mechanisms responsible for the health effects of DEPs requires the evaluation of DEP standards for
a variety of end points, and our results highlight the need for multidisciplinary studies on a variety
of representative samples of DEPs. Key words: bioassay-directed fractionation, diesel particulates,
Salmonella mutagenicity, SRM 2975. Environ Health Perspect 112:814–819 (2004).
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Research ArticleECDY dynamometer (Meiden-Sya, Tokyo,
Japan) and was run at 2,000 rpm.
SRM 2975 was generated by a forklift truck
and was purchased from NIST (Gaithersburg,
MD, USA). The DEPs were generated by
a heavy-duty diesel engine and collected
using a filtering system designed for diesel
forklifts under “hot” conditions without a
dilution tunnel at the Donaldson Company,
Inc. (Minneapolis, MN, USA; personal com-
munication). The certified analyses of these
particles are available (NIST 2000).
Organic extractions and fractionation.
DEPs were sonicated for 20 min in dichloro-
methane (DCM) at 2× the estimated volume
of the particles, and the tube was centrifuged at
approximately 2,000 rpm for 10 min. The sol-
vent was transferred to another glass tube, and
the extraction was repeated two more times.
The pooled solvent extract was concentrated,
and the percentage of extractable organic
material (EOM) was determined by gravimet-
ric measurement. The remaining extract was
concentrated to 1 mL and readjusted to 5 mL
with hexane.
Silica gel (10 g of grade 62, 60–200 mesh)
was added to a 40 × 300 mm open column
with a medium-porosity ground-glass frit.
The silica was washed with DCM followed by
hexane. The extract was added to the column,
and the EOM was eluted serially with hexane,
50:50 hexane:DCM, DCM, and methanol.
Each fraction was then concentrated under
nitrogen, and the mass of EOM for each frac-
tion was determined as described above for
the whole extract. Stock solutions at 20 µg of
EOM/mL in dimethyl sulfoxide (DMSO) of
the whole extract and each fraction were
prepared for bioassay by solvent exchange.
Mutagenicity assays. The EOM and frac-
tions from each DEP sample were evaluated for
mutagenicity in the standard plate-incorpora-
tion Salmonella (Ames) mutagenicity assay
(Maron and Ames 1983). The strains used were
the base-substitution strain TA100 (hisG46,
rfa, ∆uvrB, pKM101) and the frameshift strain
TA98 (hisD3052, rfa, ∆uvB, pKM101) (Maron
and Ames 1983); the nitroreductase- and dini-
troreductase-deficient strains TA98NR and
TA98/1,8-DNP6, respectively, which are
derivatives of TA98 (McCoy et al. 1983;
Rosenkranz 1981); and the acetyltransferase-
and nitroreductase-overexpressing strains
YG1024 (Watanabe et al. 1990) and YG1021
(Watanabe et al. 1989), respectively, which are
also derivatives of TA98.
Aroclor-induced Sprague-Dawley rat liver
S9 was obtained from Moltox (Boone, NC,
USA) and used at 1 mg S9 protein/plate. Plates
were incubated for 3 days, the colonies were
counted, and linear regressions were calculated
over the linear portion of the dose–response
curves to determine the mutagenic potencies
expressed as revertants (rev) per microgram.
A positive result was deﬁned as a reproducible,
dose-related response that at least approached a
2-fold increase in rev relative to the control. All
experiments were performed twice using either
two plates per dose (whole extracts) or one
plate per dose (fractions). Thus, results are the
average of two independent experiments.
DMSO was the negative control, and the
positive controls were 2-aminoanthracene
(0.5 µg/plate) in TA98 +S9 and TA100 +S9;
2-nitrofluorene (3 µg/plate) in TA98 –S9,
TA98NR –S9, TA98/1,8-DNP6 –S9, YG1024
–S9, and YG1021 –S9; and sodium azide
(3 µg/plate) in TA100 –S9.
Results
Mutagenic potencies of EOM. The basis for
the interpretation of the mutagenicity data is
summarized in Table 1, and the mutagenicity
dose–response data for the EOM samples are
shown in Table 2. The mutagenic potencies
derived from the dose–response data for both
the EOM and particles are shown in Table 3.
The A-EOM exhibited 18× more PAH-type
mutagenic activity (TA100 +S9) than did the
SRM 2975 EOM (Table 3). In the absence
of S9, the base-substitution mutagenic
potency (TA100) of the SRM 2975 EOM
was 3× greater than that of the A-EOM. The
two EOM samples had rather similar
frameshift mutagenic potencies (TA98);
however, the SRM 2975 EOM had 2.3×
more frameshift activity in the absence of S9
than in the presence of S9 (Table 3). Also, the
SRM 2975 EOM had 5× more frameshift
potency than base-substitution potency in the
presence of S9. In the absence of S9, the rank-
ings of the mutagenic potencies among the
strains, with the exception of TA100, were
similar for the two EOM samples (Table 3).
Table 4 shows the inferred contribution of
nitroarenes to the mutagenic activity of the
DEPs. Based on comparative results between
TA98 and either TA98/1,8-DNP6 or YG1024,
the EOM of SRM 2975 had approximately 2×
more nitroarene-type mutagenic activity than
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Table 1. Interpretation of Salmonella data.
Mutagenicity Inference
TA100 +S9 > TA98 +S9 PAH-type mutagenicity because PAHs are more mutagenic in TA100 than in TA98 
(DeMarini et al. 1994)
TA98 –S9 > TA98NR –S9 Nitroarene-type mutagenicity because nitroarenes require nitroreductase for
mutagenicity, and some of this is missing in TA98NR (Rosenkranz 1981)
TA98 –S9 > TA98/1,8-DNP6 –S9 Dinitroarene-type mutagenicity because TA98/1,8-DNP6 is missing a reductase
that activates some dinitroarenes (McCoy et al. 1983)
YG1021 –S9 > TA98 –S9 Nitroarene-type mutagenicity because YG1021 contains additional nitroreductase 
to activate nitroarenes to mutagens (Einistö et al. 1991)
YG1024 –S9 > TA98 –S9 Nitroarene- and/or aromatic amine-type mutagenicity because YG1024 contains
acetyltransferase that activates these chemical classes to mutagens (Einistö
et al. 1991)
Table 2. Mutagenicity of organic extracts of DEPs in Salmonella.
Rev/platea
A-DEP SRM 2975
Strain EOM/plate (µg) +S9 –S9 +S9 –S9
TA100 0.0 29 18 29 18
0.5 114 103 87 110
1.0 191 214 121 208
2.0 314 299 225 456
TA98 0.0 81 75 81 75
0.5 303 113 92 101
1.0 497 161 99 99
2.0 780 245 118 132
TA98NR 0.0 28 28
0.5 30 47
1.0 43 60
2.0 41 71
TA98/1,8-DNP6 0.0 16 16
0.5 26 28
1.0 35 29
2.0 47 46
YG1024 0.0 24 24
0.5 287 663
1.0 563 1,204
2.0 1,049 1,992
YG1021 0.0 27 27
0.5 188 129
1.0 353 226
2.0 652 435
aData are the average of two independent experiments, each having two plates per dose; thus, the data are the average
of four plates per dose.did the A-EOM. However, based on data from
strain YG1021, the opposite result was found,
with the A-EOM having approximately 174×
more nitroarene-type mutagenic activity than
did the SRM 2975 EOM.
Mutagenic potencies of particles. To
convert the mutagenic potencies of the EOM
(rev per microgram of EOM) to mutagenic
potencies of the particles (rev per microgram of
particle), the potencies of the EOM were mul-
tiplied by the percent EOM of the particle.
The percent EOM was 26.3% for A-DEPs and
2% for SRM 2975. Based on these calcula-
tions, the A-DEPs had 227× more PAH-type
mutagenic activity (TA100 +S9) than did the
SRM 2975 particles. In addition, the A-DEPs
had approximately 8× more nitroarene-type
activity than did the SRM 2975 particles based
on data from TA98NR, TA98/1,8-DNP6, or
YG1024 (Table 4). Based on data from strain
YG1021, the A-DEPs had even more (45×)
nitroarene-type mutagenic activity than did the
SRM 2975 particles. The A-DEPs had greater
mutagenic potency in both TA98 and TA100
than did the SRM 2975 particles (Table 3),
perhaps due to higher amounts of nitroarene-
and aromatic amine-type mutagenic activity in
the A-DEP sample relative to the SRM 2975
sample. Except for the juxtaposition of TA98
and TA100, the mutagenic potency rankings
of the two DEPs were similar among the
strains (Table 3).
Mutagenic potencies of fractions of EOM.
The dose–response data for the fractions are
shown in Table 5, and the mutagenic poten-
cies of the fractions of the two EOM are
shown in Table 6. For example, in TA100
+S9, the most potent A-EOM eluted in the
hexane/DCM and DCM fractions, whereas
the most potent SRM 2975 EOM eluted in
the DCM fraction. Thus, the classes of com-
pounds accounting for S9-dependent, base-
substitution mutagenicity in the A-EOM
were less polar than were those in the SRM
2975 EOM. When comparing the reduction
in mutagenic potencies in TA98NR relative
to TA98, which is an indication of the
presence of nitroarenes, the greatest reduction
for the SRM 2975 EOM occurred in the
hexane/DCM fraction, whereas the greatest
reduction for the A-EOM occurred in the
DCM and methanol fractions, which are
much more polar than hexane/DCM. A vari-
ety of other differences of this sort can be
noted by comparing the results in Table 6.
Distribution of recovered mass and muta-
genicity of EOM. Most (84%) of the mass of
the A-EOM and all (103%) of the mass of the
SRM 2975 EOM were recovered from the sil-
ica-gel column after the fractionation (Tables 7
and 8). However, the distribution of the mass
across the fractions was the opposite for the
two EOM (Tables 7 and 8, Figure 1). Thus,
approximately 55% of the A-EOM eluted in
the hexane fraction and approximately 33% in
the highly polar methanol fraction, whereas
approximately 29% of the SRM 2975 EOM
eluted in the hexane fraction and approxi-
mately 58% in the methanol fraction.
Likewise, the distribution of mutagenicity
across the fractions was different for the two
EOMs. For example, 3× more PAH-type
mutagenic activity (TA100 +S9) eluted in the
hexane/DCM fraction from the A-EOM than
from the SRM 2975 EOM (Tables 7 and 8,
Figure 2), conﬁrming our other data that the
A-DEP sample had more PAH-type mutagenic
activity than did the SRM 2975. The distribu-
tion of direct-acting, base-substitution muta-
genic activity (TA100 –S9) was completely the
opposite for the two EOMs, with most of this
activity eluting in the hexane/DCM fraction for
the A-EOM but in the polar methanol fraction
for the SRM 2975 EOM (Tables 7 and 8). The
direct-acting frameshift mutagenic activity
requiring minimal nitroreductase (TA98NR
–S9) was due to compounds having a range of
polarity for the A-EOM, because this activity
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Table 4. Comparative amounts of nitroarene-type mutagenic activity between the two DEPs.
Straina EOM Particles
TA98NR SRM 1.6× > A-DEP A-DEP 8.5× > SRM
TA98/1,8-DNP6 SRM 1.7× > A-DEP A-DEP 7.9× > SRM
YG1024 SRM 2× > A-DEP A-DEP 6.5× > SRM
YG1021 A-DEP ~174× > SRM A-DEP 45× > SRM
aComparisons were made by determining the difference in mutagenic potency for each EOM or particle in Table 3
between TA98 –S9 and the strains listed above –S9. For example, for EOM in TA98NR, 138.5 – 15.5 (rev/µg in TA98 –
TA98NR) = 123 rev/µg; for SRM 2975 this was 218.1 – 27.3 = 190.8 rev/µg. Then, 190.8 ÷ 123 = 1.6; thus, based on data in
TA98NR, SRM 2975 EOM had 1.6× more nitroarene-type mutagenic activity than did A-EOM.
Table 5. Mutagenicity and mutagenic potencies of fractions of organic extract of DEPs in Salmonella.
Rev/plate
a
EOM/ A-DEP SRM 2975
Strain plate (µg) H H/DCM DCM M H H/DCM DCM M
TA100 +S9 0.0 110 110 110 110 89 89 89 89
0.25 731 532
0.5 112 1,008 849 167 90 135 176 133
1.0 108 1,573 1,015 231 95 163 153 146
2.0 111 1,486 1,010 398 90 235 523 199
TA100 –S9 0.0 110 110 110 110 90 90 90 90
0.25 136
0.5 110 149 255 149 84 137 408 155
1.0 115 215 322 181 99 163 662 184
2.0 120 347 508 256 92 239 1,017 258
TA98 +S9 0.0 46 46 46 46 32 32 32 32
0.5 56 221 231 80 38 60 172 80
1.0 47 347 381 102 41 75 351 126
2.0 47 570 658 161 45 123 960 204
TA98 –S9 0.0 31 31 31 31 22 22 22 22
0.25 986
0.5 46 89 197 80 28 86 1,962 108
1.0 44 118 394 113 24 162 2,702 211
2.0 39 200 736 189 27 314 2,448 432
TA98NR –S9 0.0 24 24 24 24 17 17 17 17
0.25 573
0.5 30 45 55 40 21 30 848 37
1.0 27 57 80 36 20 37 1,494 55
2.0 30 74 117 46 22 48 1,743 81
Abbreviations: H, hexane; H/DCM, hexane/DCM; M, methanol. 
aData are the average of two independent experiments, each of which had one plate per dose; thus, data shown are the
average of two plates per dose.
Table 3. Mutagenic potencies of EOM and particles of DEPs in Salmonella.
Rev/µg EOMa Rev/µg particlea
A-DEP SRM 2975 A-DEP SRM 2975
Strain +S9 –S9 +S9 –S9 +S9 –S9 +S9 –S9
TA100 345.2 85.9 19.0 262.0 90.8 22.6 0.4 5.2
TA98 155.3 138.5 96.0 218.1 40.8 36.4 1.9 4.4
TA98NR 15.5 27.3 4.1 0.6
TA98/1,8-DNP6 15.3 14.0 4.0 0.3
YG1024 512.7 970.0 134.8 19.4
YG1021 312.5 203.4 82.2 4.1
aData are the average slopes of linear regressions calculated over the linear portion of the dose–response curves from
two independent experiments, each of which had two plates per dose (Table 2).was dispersed across three fractions, whereas for
the SRM 2975 EOM, > 80% of this activity
eluted in only the DCM fraction. Despite the
many differences, one feature was identical for
both EOM: neither had detectable mutagenic
activity in the hexane fraction. This was true
even for the A-EOM, despite approximately
55% of its mass eluting in the hexane fraction.
Discussion
Mutagenicity of EOM and DEPs. DCM is the
most effective solvent for the extraction of
mutagenic organics from diesel exhaust
(Montreuil et al. 1992; Petersen and Chuang
1982); therefore, it was used here to prepare the
initial organic extract of both DEP samples.
Although the mutagenicity of SRM 2975
EOM in several strains of Salmonella had been
reported previously (Hughes et al. 1997), this
sample had not been subjected previously to a
bioassay-directed fractionation of the type
described here, and no mutagenicity data had
been reported previously for the A-EOM.
With regard to the whole, unfractionated SRM
2975 EOM, the mutagenic potency ranking in
the absence of S9 among the strains obtained
here was similar to that obtained previously by
Hughes et al. (1997) except that our sample
ranked as more potent in TA100 than that of
Hughes et al. (1997). One possible reason is
that Hughes et al. (1997) evaluated the soxh-
let extract of SRM 2975 purchased from
NIST, whereas we prepared our own extract
by sonication from SRM 2975.
In the absence of S9, the mutagenic
potency of the SRM 2975 EOM was generally
greater than that of the A-EOM; the opposite
was the case in the presence of S9 (Table 3).
However, when the mutagenic potencies of the
EOM were combined with the percent EOM
of the particles, the mutagenic potency of the
A-DEPs per mass of particle was greater in all
strains than that of the SRM 2975 DEP
regardless of S9 (Table 3). This occurred partly
because the A-DEPs had > 10× the percent
EOM than did SRM 2975. The A-DEPs had
227× more PAH-type activity and approxi-
mately 8–45× more nitroarene-type activity
than did the SRM 2975 particles. The A-DEPs
also had 3–21× more frameshift mutagenic
activity than did the SRM 2975 particles,
which was most likely due to the excess
amount of nitroarene and possibly aromatic
amine activity in the A-DEPs. Considering the
various strains used to infer the proportion of
nitroarene-type mutagenic activity in the
samples, all the strains but YG1021 led to simi-
lar conclusions (Table 4). Perhaps the addi-
tional nitroreductase present in YG1021
activated many compounds present at low con-
centrations that were not activated by the nor-
mal levels of nitroreductase present in TA98.
Thus, continued caution must be exercised
regarding inferences about the role of
nitroarenes in the mutagenicity of DEPs using
these and other such strains (Rosenkranz 1981).
Mutagenicity of fractions of EOM.
Various methods have been used to fractionate
organic extracts of diesel particles, including
acid/base/neutral fractionation procedures
(Crebelli et al. 1991) and solid-phase extrac-
tions using Sephadex (Bechtold et al. 1985) or
silica gel (Hayakawa et al. 1997; Strandell
et al. 1994). Hexane is a neutral solvent in
which chemical classes such as alkanes and
alkenes elute (Hayakawa et al. 1997), whereas
methanol is a highly polar solvent in which
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Table 8. Distribution of mass and mutagenicity among fractions of organic extract of SRM 2975.
Mass
Recovery Distribution of Distribution of recovered mutagenicity (%)a
Sample EOM (µg) (%) recovered mass (%) TA100 +S9 TA100 –S9 TA98 +S9 TA98 –S9 TA98NR –S9
Whole 8,430
Hexane 2,550 30.3 29.1 0.0 0.0 0.0 0.0 0.0
Hexane/DCM 560 6.6 6.4 13.7 5.8 3.5 3.2 0.9
DCM 550 6.5 6.3 41.0 35.6 36.0 56.3 82.1
Methanol 5,090 60.4 58.2 45.3 58.6 60.5 40.5 17.0
Σ Fractions 8,750 103.8 100.0 100.0 100.0 100.0 100.0 100.0
aCalculated by multiplying the number of rev/µg for each fraction from Table 6 by the number of micrograms of EOM recovered for each fraction as noted in the second column of this table.
These values, rev/fraction, were then expressed as a percentage relative to the sum (Σ) of the recovered mass of the fractions noted in the second column of this table.
Table 7. Distribution of mass and mutagenicity among fractions of organic extract of A-DEP.
Mass
Recovery Distribution of Distribution of recovered mutagenicity (%)a
Sample EOM (µg) (%) recovered mass (%) TA100 +S9 TA100 –S9 TA98 +S9 TA98 –S9 TA98NR –S9
Whole 53,680
Hexane 24,850 46.3 54.8 0.0 0.0 0.0 0.0 0.0
Hexane/DCM 2,690 5.0 5.9 40.6 80.7 28.7 10.4 22.5
DCM 2,890 5.4 6.4 36.7 13.7 36.3 42.1 40.8
Methanol 14,880 27.7 32.9 22.7 5.6 35.0 47.5 36.7
Σ Fractions 45,310 84.4 100.0 100.0 100.0 100.0 100.0 100.0
aCalculated by multiplying the number of rev/µg for each fraction from Table 6 by the number of micrograms of EOM recovered for each fraction as noted in the second column of this table.
These values, rev/fraction, were then expressed as a percentage relative to the sum (Σ) of the recovered mass of the fractions noted in the second column of this table.
Figure 1. Distribution of mass of EOM of DEPs
across four fractions of increasing polarity. A DCM
extract of each DEP resulted in the EOM, which was
then fractionated on a silica-gel column by sequen-
tial extraction with solvents of increasing polarity:
hexane (H), H/DCM, DCM, and methanol (M).
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Table 6. Mutagenic potencies (rev/µg) of fractions of EOM of DEPs in Salmonella.
A-DEPa SRM 2975a
Strain H H/DCM DCM M H H/DCM DCM M
TA100 +S9 0.0 1430.4 1204.0 145.0 0.0 71.5 217.4 52.0
TA100 –S9 0.0 122.7 191.9 72.7 0.0 73.0 452.9 80.9
TA98 +S9 0.0 256.7 302.2 56.7 0.0 44.8 471.5 85.8
TA98 –S9 0.0 94.2 354.9 77.7 0.0 149.5 2662.1 206.9
TA98NR –S9 0.0 31.5 53.2 9.3 0.0 14.7 1407.4 31.5
Abbreviations: H, hexane; H/DCM, hexane/DCM; M, methanol. 
aData are average slopes of linear regressions calculated from the linear portion of the dose–response curves from two
independent experiments, each of which had one plate per dose (Table 5).compounds such as oxygenated aromatics
elute (Strandell et al. 1994). PAHs, aromatic
amines, and nitroarenes can elute in the
hexane/DCM and DCM fractions (Hayakawa
et al. 1997; Schuetzle 1983). Hayakawa et al.
(1997) showed that as much as 53% of the
mutagenicity of the DCM fraction of DEPs
was due to nitroarenes.
As summarized by Singh et al. (2004), the
two DEP samples had different physical prop-
erties, chemical compositions, and pulmonary
toxicities. The mass and mutagenicity dis-
tributions of the two samples described here
reflected clear differences in the chemical
composition of these DEPs. The mass distrib-
utions of the fractionated extracts of the two
DEP samples were the opposite of each other,
with most of the A-EOM eluting in the
hexane fraction but most of the SRM 2975
EOM eluting in the highly polar methanol
fraction. The lack of mutagenic activity in the
hexane fraction (Tables 7 and 8) was consis-
tent with the presence of unsubstituted alka-
nes and alkenes, which are not mutagenic.
These results are also supported by the pho-
tomicrographs and other chemical and com-
bustion data demonstrating that much of the
A-EOM is uncombusted fuel, possibly neutral
alkanes and alkenes (Singh et al. 2004), which
would have eluted in the hexane fraction.
As reported previously (Hayakawa et al.
1997), the sum of the mutagenic potencies of
the EOM across the fractions was generally
much higher than that of the whole, unfrac-
tionated material, and this was true for all the
strains used here. For example, in TA98 –S9,
the mutagenic potency of the A-EOM was
138.5 rev/µg (Table 3), but the sum of the
potencies of the fractions in this strain was
526.8 rev/µg (Table 7). Likewise, the muta-
genic potency of the SRM 2975 EOM was
218.1 rev/µg, but that of the sum of its frac-
tions was 3018.5 rev/µg, an approximately
14× increase. This showed that the fractiona-
tion unmasked the mutagenic potency of the
compounds by separating some of the non-
mutagenic cytotoxic compounds from the
mutagenic compounds in the mixture. The
ability of the fractionation to separate a large
amount of nonmutagenic mass from muta-
genic mass (Tables 7 and 8, Figure 1) is one
of the goals of a successful bioassay-directed
fractionation (Schuetzle and Lewtas 1986).
As shown previously, the distribution of
mutagenic activity of the EOM across chemical
fractions can vary depending on the type of
engine (Clark et al. 1981; Sjogren et al. 1996),
type of fuel (Clark et al. 1982; Crebelli et al.
1995; Sjogren et al. 1996; Westerholm et al.
2001), the running conditions (Bechtold et al.
1984; Courtois et al. 1993), and the collection
conditions (Claxton and Barnes 1981; Lies
et al. 1986). As demonstrated by extensive stud-
ies, much of the mutagenic activity of diesel
exhaust is due to PAHs and nitroaromatics,
especially nitropyrenes (Austin et al. 1985;
Claxton 1981, 1983; Lies et al. 1986;
Nakagawa et al. 1983; Rosenkranz 1996;
Tokiwa and Ohnishi 1986). An important role
for direct-acting acid/neutral compounds that
are not nitropyrenes has also been noted
(Crebelli et al. 1991). In this regard, the direct-
acting, base-substitution mutagenicity (TA100
–S9) of the two EOM eluted in opposite frac-
tions, indicating that different chemicals
accounted for this activity for the two samples.
The mutagenic potencies of most of the
fractions of the A-EOM were enhanced by S9
(Table 6), whereas the opposite result was
found for the SRM 2975 EOM. This indi-
cated that, across chemical classes, A-EOM
contained more S9-dependent mutagenicity
than did the SRM 2975 EOM. Consistent
with this is the evidence presented here and by
Singh et al. (2004) for greater amounts of
PAH-type mutagenicity and PAHs in the
A-DEPs compared with SRM 2975. There is
ample evidence that the genotoxic activity asso-
ciated with the EOM of DEPs inhaled into the
lung may be bioavailable by virtue of the solu-
bilization and dispersion properties of pul-
monary surfactant components (Belisario et al.
1984; Keane et al. 1991; King et al. 1981).
Conclusions
A summary of some of the relative differences
between the two DEPs (Table 9) shows that
they have disparate mutagenic activities and
chemical compositions due to the different con-
ditions under which they were generated and
collected. The fact that one sample (A-DEPs)
has been used extensively in pulmonary toxicity
studies but never studied previously for muta-
genicity, and virtually the opposite situation
pertains for the other sample (SRM 2975),
illustrates the need for scientists to engage in
collaborative, multidisciplinary research efforts
in this area. Similar to the mutagenic activities
of these particles, the pulmonary toxicities of
these two DEPs were also strikingly different
(Singh et al. 2004). These biologic data, com-
bined with the physical and chemical features
of these two DEPs (Singh et al. 2004), provide
a basis for comparing these two DEPs that was
not available previously.
A screening battery for a variety of DEPs
involving pulmonary toxicity and mutagenicity
has been proposed by Seagrave et al. (2002),
and this could be extended to include a bioas-
say-directed fractionation as shown here. Until
comparative data among a variety of DEP sam-
ples for various end points are available, a com-
prehensive understanding of the mechanisms
associated with the health effects of any DEPs
will be hindered (HEI 2002).
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